De Novo Peptide and Protein Design Using Generative Adversarial Networks: An Update.

E Lin, Chia-Hung Lin, HY Lane

Research output: Contribution to journalJournal Article peer-review

14 Scopus citations

Abstract

Nowadays, machine learning and deep learning approaches are widely utilized for generative chemistry and computer-aided drug design and discovery such as de novo peptide and protein design, where target-specific peptide-based/protein-based therapeutics have been suggested to cause fewer adverse effects than the traditional small-molecule drugs. In light of current advancements in deep learning techniques, generative adversarial network (GAN) algorithms are being leveraged to a wide variety of applications in the process of generative chemistry and computer-aided drug design and discovery. In this review, we focus on the up-to-date developments for de novo peptide and protein design research using GAN algorithms in the interdisciplinary fields of generative chemistry, machine learning, deep learning, and computer-aided drug design and discovery. First, we present various studies that investigate GAN algorithms to fulfill the task of de novo peptide and protein design in the drug development pipeline. In addition, we summarize the drawbacks with respect to the previous studies in de novo peptide and protein design using GAN algorithms. Finally, we depict a discussion of open challenges and emerging problems for future research.
Original languageAmerican English
JournalJournal of Chemical Information and Modeling
Volume62
Issue number4
DOIs
StatePublished - 2022

Fingerprint

Dive into the research topics of 'De Novo Peptide and Protein Design Using Generative Adversarial Networks: An Update.'. Together they form a unique fingerprint.

Cite this